Home  >  News
Eppen_Himac_Jan25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
News
  Rappta Therapeutics enters global license agreement with SpringWorks for a pre-clinical first-in-class molecular glue targeting PP2A,   January 14, 2025
  Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb,   January 14, 2025
  US FDA accepts and grants priority review status to AstraZeneca & Daiichi Sankyo’s BLA for Dato-DXd for patients with previously treated advanced EGFR-mutated NSCLC,   January 14, 2025
  BioDuro opens new solid-phase peptide synthesis scale-up facility in China,   January 13, 2025
  GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion,   January 13, 2025
  New European Union rules for health technology assessments become effective,   January 13, 2025
  FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025,   January 11, 2025
  Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology,   January 11, 2025
  Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market,   January 11, 2025
  US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis,   January 11, 2025
  Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy,   January 11, 2025
  Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development,   January 10, 2025
  Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report,   January 10, 2025
  China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases,   January 10, 2025
  Basel ranked best location for drug device innovation in Europe,   January 10, 2025
  Bayer’s subsidiary, Vividion acquires Tavros Therapeutics to expand functional genomics capabilities and boost drug discovery platform,   January 10, 2025
  US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins,   January 09, 2025
  US FDA clears Solid Biosciences’ IND application for SGT-212 to treat neurologic & cardiac manifestations of Friedreich’s ataxia,   January 09, 2025
  Alloy Therapeutics announces target specific collaboration & license agreement for use of AntiClastic Antisense platform with Sanofi for CNS target,   January 09, 2025
  Phillips Medisize expands its inhalation drug delivery capabilities,   January 09, 2025

  • Results Found: 21535
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 1077
 Back
 
Asia_Lab_Expo2025
chemexpoindia
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram